Form 4: Abbott Laboratories Executive Vice President Reports Stock Disposals

Sentiment:

SEC Form 4 Filing


Louis H. Morrone, Executive Vice President of Abbott Laboratories, reports the disposal of common shares to cover tax obligations.

Summary

  • Louis H. Morrone, an Executive Vice President at Abbott Laboratories, filed a Form 4 detailing changes in beneficial ownership.
  • On June 30, 2024, he disposed of 269 common shares at a price of $103.91.
  • On July 1, 2024, he disposed of 556 common shares at a price of $103.91.
  • Following these transactions, Morrone directly owns 62,143 common shares.
  • He also indirectly owns 2,618 common shares through a Profit Sharing Trust as of June 30, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock disposals by an executive, which is a routine occurrence. There is no indication of positive or negative implications for the company.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with SEC regulations.

Stakeholder Impact

  • The stock disposal may have a minor impact on shareholders due to the increased supply of shares, but the effect is likely minimal given the relatively small number of shares involved.

Key Dates

DateDescription
06/30/2024Date of transaction: Disposal of 269 common shares.
06/30/2024Balance in the Abbott Laboratories Stock Retirement Trust.
07/01/2024Date of transaction: Disposal of 556 common shares.
07/02/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.